Disc Medicine
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 37 pending · first 2023
- Rank in peer group#339 of 1449
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextStanding among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#339 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 3 granted of 40- GrantedMethods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With Glycine Transport InhibitorsUSPTOUS 12,721,847
- PendingMethods For Treating Myelofibrosis And Related ConditionsUSPTOApplication 19334737
- PendingCompositions And Methods For Treating PolycythemiaUSPTOApplication 18280837
Show all 40 patent records
- Methods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With Glycine Transport InhibitorsSep 1, 2026 · US 12,721,847Granted
- Methods For Treating Myelofibrosis And Related ConditionsMay 28, 2026 · Application 19334737Pending
- Compositions And Methods For Treating PolycythemiaJan 29, 2026 · Application 18280837Pending
- Methods For Treating Blood Loss ConditionsOct 9, 2025 · Application 18872447Pending
- Compositions And Methods For Treating Hepatic Porphyrias With Glycine Transport InhibitorsOct 2, 2025 · Application 18866586Pending
- Matriptase 2 Inhibitors And Uses ThereofSep 30, 2025 · US 12,428,415Granted
- Methods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With Glycine Transport InhibitorsAug 21, 2025 · Application 18941469Pending
- Compositions And Methods For Treating PolycythemiaAug 7, 2025 · Application 18923904Pending
- Methods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With Glycine Transport InhibitorsJul 17, 2025 · Application 19077940Pending
- ANTI-TMPRSS6 Antibodies And Uses ThereofMay 1, 2025 · Application 18673941Pending
- Amine Based Matriptase 2 Inhibitors And Uses ThereofDec 5, 2024 · Application 18632780Pending
- Methods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With A Solid Form Of BitopertinNov 28, 2024 · Application 18562510Pending
- Methods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With Glycine Transport InhibitorsNov 7, 2024 · Application 18290403Pending
- Compositions And Methods For Treating Anemia Associated With A Ribosomal DisorderOct 3, 2024 · Application 18280774Pending
- Peptidomimetic Matriptase 2 Inhibitors And Uses ThereofSep 26, 2024 · Application 18268107Pending
- Compositions And Methods For Treating PolycythemiaAug 15, 2024 · Application 18596341Pending
- Methods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With Glycine Transport InhibitorsNov 14, 2023 · US 11,813,257Granted
- Methods For Treating Anemia Of Chronic DiseaseNov 24, 2022 · Application 17764143Pending
- Methods For Treating Myelofibrosis And Related ConditionsNov 24, 2022 · Application 17764142Pending
- Amine Based Matriptase 2 Inhibitors And Uses ThereofApplication 63458772Pending
- ANTI-TMPRSS6 Antibodies And Uses ThereofApplication 63457081Pending
- Methods For Treating Anemia Of Kidney DiseaseApplication PCTUS2022079987Pending
- Methods For Treating Blood Loss ConditionsApplication 63350766Pending
- Compositions And Methods For Treating Hepatic Porphyrias With Glycine Transport InhibitorsApplication 63347415Pending
- Methods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With A Solid Form Of BitopertinApplication PCTUS2022031081Pending
- Methods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With Glycine Transport InhibitorsApplication PCTUS2022029283Pending
- Compositions And Methods For Treating PolycythemiaApplication PCTUS2022020038Pending
- Compositions And Methods For Treating Anemia Associated With A Ribosomal DisorderApplication PCTUS2022020039Pending
- Peptidomimetic Matriptase 2 Inhibitors And Uses ThereofApplication PCTUS2021063770Pending
- Methods For Treating Anemia Of Kidney DiseaseApplication 63280594Pending
- Methods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With A Solid Form Of BitopertinApplication 63193898Pending
- Methods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With Glycine Transport InhibitorsApplication 63188489Pending
- Compositions And Methods For Treating PolycythemiaApplication 63185464Pending
- Compositions And Methods For Treating Anemia Associated With A Ribosomal DisorderApplication 63185466Pending
- Anti-hemojuvelin (hjv) Antibodies For Treating MyelofibrosisApplication 63164294Pending
- Anti-hemojuvelin (hjv) Antibodies For Treating Anemia Of Chronic DiseaseApplication 63164307Pending
- Compositions And Methods For Treating PolycythemiaApplication 63160412Pending
- Compositions And Methods For Treating Anemia Associated With A Ribosomal DisorderApplication 63160413Pending
- Methods Of Treating Erythropoietic Protoporphyria, X-linked Protoporphyria, Or Congenital Erythropoietic Porphyria With Glycine Transport InhibitorsApplication PCTUS2021012786Pending
- Peptidomimetic Matriptase 2 Inhibitors And Uses ThereofApplication 63127008Pending
Related companies, and why
- Artielle ImmunoTherapeutics IncSimilar federal contract value in Biotech · null in contracts
- Virocell Biologics LtdSimilar federal contract value in Biotech · null in contracts
- Pylum Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- MULTITARGA LLCSimilar federal contract value in Biotech · null in contracts
- Neuromed PharmaceuticalsSimilar federal contract value in Biotech · null in contracts
- Macrotope, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .